Plant-Derived Extracellular Vesicles as a Novel Frontier in Cancer Therapeutics
Nanomaterials · 08.08.2024 · 14 (16) · 1331
DOI: 10.3390/nano14161331 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Nanomaterials, online erschienen am 08.08.2024. Verfasst von Lishan Cui und 4 weiteren Autor:innen. Beteiligte Einrichtung: Dipartimento di Neuroscienze, Università Cattolica del Sacro Cuore, Largo Francesco Vito 1, 00168 Rome, Italy. Die Arbeit wurde bisher 33-mal zitiert (Crossref) und nennt 85 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Fondazione Umberto Veronesi.
Abstract (Originalsprache)
Recent advancements in nanomedicine and biotechnology have unveiled the remarkable potential of plant-derived extracellular vesicles (PDEVs) as a novel and promising approach for cancer treatment. These naturally occurring nanoscale particles exhibit exceptional biocompatibility, targeted delivery capabilities, and the capacity to load therapeutic agents, positioning them at the forefront of innovative cancer therapy strategies. PDEVs are distinguished by their unique properties that facilitate tumor targeting and penetration, thereby enhancing the efficacy of drug delivery systems. Their intrinsic biological composition allows for the evasion of the immune response, enabling the efficient transport of loaded therapeutic molecules directly to tumor sites. Moreover, PDEVs possess inherent anti-cancer properties, including the ability to induce cell cycle arrest and promote apoptotic pathways within tumor cells. These vesicles have also demonstrated antimetastatic effects, inhibiting the spread and growth of cancer cells. The multifunctional nature of PDEVs allows for the simultaneous delivery of multiple therapeutic agents, further enhancing their therapeutic potential. Engineering and modification techniques, such as encapsulation, and the loading of therapeutic agents via electroporation, sonication, and incubation, have enabled the customization of PDEVs to improve their targeting efficiency and therapeutic load capacity. This includes surface modifications to increase affinity for specific tumor markers and the encapsulation of various types of therapeutic agents, such as small molecule drugs, nucleic acids, and proteins. Their plant-derived origin offers an abundant and renewable source to produce therapeutic vesicles, reducing costs and facilitating scalability for clinical applications. This review provides an in-depth analysis of the latest research on PDEVs as emerging anti-cancer agents in cancer therapy.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Dipartimento di Neuroscienze, Università Cattolica del Sacro Cuore, Largo Francesco Vito 1, 00168 Rome, Italy.
- Fondazione Policlinico Universitario A. Gemelli IRCSS, 00168 Rome, Italy.
- Istituto dei Sistemi Complessi, Consiglio Nazionale delle Ricerche CNR, Via dei Taurini 19, 00185 Rome, Italy.
ORCID-Profile: Giordano Perini, Marco De Spirito, Massimiliano Papi
Förderung
- Fondazione Umberto Veronesi
Zitieren
APA
Cui, L., Perini, G., Palmieri, V., De Spirito, M., & Papi, M. (2024). Plant-Derived Extracellular Vesicles as a Novel Frontier in Cancer Therapeutics. Nanomaterials, 14(16), 1331. https://doi.org/10.3390/nano14161331
Vancouver
Cui L, Perini G, Palmieri V, De Spirito M, Papi M. Plant-Derived Extracellular Vesicles as a Novel Frontier in Cancer Therapeutics. Nanomaterials. 2024;14(16):1331. doi:10.3390/nano14161331
BibTeX
@article{Cui2024,
author = {Cui, Lishan and Perini, Giordano and Palmieri, Valentina and De Spirito, Marco and Papi, Massimiliano},
title = {Plant-Derived Extracellular Vesicles as a Novel Frontier in Cancer Therapeutics},
journal = {Nanomaterials},
year = {2024},
volume = {14},
number = {16},
pages = {1331},
doi = {10.3390/nano14161331}
}
EUVIMED